FIELD: medicine, gynecology, clinical immunology. SUBSTANCE: for treatment of yeast colpitis with resistance to standard therapy invention proposes to use medicinal plant species as drug that consist of three components: desensitizating, immunocorrecting (by oral use) properties and topical antimycotic property (by topical use) in the form of infusions. Treatment course is 25 days. EFFECT: decreased time of treatment, prolonged remission period, absence of adverse effects. 4 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
HERBAL SPECIES POSSESSING DESENSITIZING ACTIVITY | 1999 |
|
RU2160600C1 |
AGENT FOR TREATMENT OF PATIENTS WITH CHRONIC CHOLESTATIC HEPATITIS | 2000 |
|
RU2175869C1 |
MEDICATION FOR TREATING INTESTINAL DYSBIOSIS IN PATIENTS WITH CHRONIC CRYPTOGENIC HEPATITIS | 2009 |
|
RU2411955C1 |
SPECIES "POLESTELL" FOR TREATMENT OF PATIENTS WITH LUNG AND UPPER RESPIRATORY WAY DISEASES | 1997 |
|
RU2132200C1 |
AGENT FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B | 2000 |
|
RU2180228C1 |
AGENT FOR TREATMENT OF CHRONIC PYELONEPHRITIS | 2001 |
|
RU2224531C2 |
AGENT FOR TREATMENT OF PATIENTS WITH HEPATITIS AND FIBROSIS SYMPTOMS | 2000 |
|
RU2164802C1 |
AGENT FOR PREVENTION AND TREATMENT OF PERIODONTAL DISEASES AND TEETH AND MOUTH CARE | 2014 |
|
RU2624518C2 |
AGENT FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS OF NONINFECTIOUS ETIOLOGY COMPLICATED BY CHRONIC PANCREATITIS | 1997 |
|
RU2139071C1 |
PHYTOCOMPLEX SHOWING ANTITUMOR EFFECT AND METHOD OF ONCOLOGICAL PATIENT TREATMENT | 1994 |
|
RU2074731C1 |
Authors
Dates
2000-08-27—Published
1998-06-08—Filed